Novo Nordisk A/S Common Stock (NVO)
EBITDA Margin
54.91%
TTM · Period ending:
NVO EBITDA Margin
Latest reported54.91%period ending
Latest reported54.91%period ending
NVO TTM EBITDA Margin (17.72% → 54.91%)
TTM ebitda margin
High-resolution chart · PNG
NVO ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 54.915% | |
| 56.6882% | |
| 52.6308% | |
| 53.4735% | |
| 55.41% | |
| 54.4262% | |
| 53.6661% | |
| 51.1898% | |
| 51.9033% | |
| 51.1315% | |
| 49.7531% | |
| 45.0142% | |
| 43.5083% | |
| 43.8494% | |
| 42.9451% | |
| 48.0254% | |
| 46.986% | |
| 45.8554% | |
| 46.4787% | |
| 47.0332% | |
| 46.9717% | |
| 47.2749% | |
| 46.6915% | |
| 44.8921% | |
| 45.0681% | |
| 44.6499% | |
| 44.6104% | |
| 46.6213% | |
| 45.5406% | |
| 46.0934% | |
| 46.2332% | |
| 46.0247% | |
| 46.651% | |
| 46.7279% | |
| 46.161% | |
| 47.2439% | |
| 47.2176% | |
| 46.4219% | |
| 45.5949% | |
| 40.9645% | |
| 40.7571% | |
| 40.829% | |
| 43.3033% | |
| 47.1053% | |
| 46.6975% | |
| 45.8452% | |
| 42.1267% | |
| 43.2431% | |
| 42.9182% | |
| 42.8406% | |
| 42.178% | |
| 40.7299% | |
| 39.613% | |
| 38.2828% | |
| 36.6404% | |
| 37.4787% | |
| 36.2845% | |
| 34.8138% | |
| 34.4919% | |
| 35.742% | |
| 36.2386% | |
| 36.9759% | |
| 37.5313% | |
| 34.4561% | |
| 34.0714% | |
| 33.718% | |
| 33.3803% | |
| 33.8859% | |
| 32.9352% | |
| 30.1861% | |
| 28.612% | |
| 24.5688% | |
| 22.9295% | |
| 23.1354% | |
| 21.3933% | |
| 23.9691% | |
| 24.0648% | |
| 24.1227% | |
| 24.739% | |
| 24.9551% | |
| 24.9736% | |
| 25.19% | |
| 23.9585% | |
| 24.7452% | |
| 24.0296% | |
| 23.392% | |
| 23.9829% | |
| -16.8675% | |
| -3.1076% | |
| 10.1333% | |
| 23.892% | |
| 14.4972% | |
| 17.6948% | |
| 17.733% | |
| 21.4766% | |
| 25.2718% | |
| 25.9026% | |
| 27.2917% | |
| 25.2708% | |
| 16.7669% |